BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27566591)

  • 21. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.
    Devapatla B; Shidal C; Yaddanapudi K; Davis KR
    F1000Res; 2016; 5():2432. PubMed ID: 28299174
    [No Abstract]   [Full Text] [Related]  

  • 24. Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation.
    Kucerova L; Demkova L; Skolekova S; Bohovic R; Matuskova M
    BMC Cancer; 2016 May; 16():308. PubMed ID: 27175734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression.
    Gu SY; Ho CC; Huang YK; Chen HW; Wang YC; Kuo CY; Teng SC; Fu WM; Yang PC; Wu CW; Peng FC; Ling TY
    Oncotarget; 2016 Mar; 7(12):13917-31. PubMed ID: 26871601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma-activated medium (PAM) kills human cancer-initiating cells.
    Ikeda JI; Tanaka H; Ishikawa K; Sakakita H; Ikehara Y; Hori M
    Pathol Int; 2018 Jan; 68(1):23-30. PubMed ID: 29235204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Pérez-Alea M; McGrail K; Sánchez-Redondo S; Ferrer B; Fournet G; Cortés J; Muñoz E; Hernandez-Losa J; Tenbaum S; Martin G; Costello R; Ceylan I; Garcia-Patos V; Recio JA
    Oncogene; 2017 Oct; 36(41):5695-5708. PubMed ID: 28581514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.
    Prasmickaite L; Engesaeter BØ; Skrbo N; Hellenes T; Kristian A; Oliver NK; Suo Z; Maelandsmo GM
    PLoS One; 2010 May; 5(5):e10731. PubMed ID: 20505780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
    Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
    Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lunasin--a novel chemopreventive peptide].
    Wołosik K; Markowska A; Kuźmicz I
    Postepy Biochem; 2014; 60(1):84-9. PubMed ID: 25033546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.
    Yasuda K; Hirohashi Y; Kuroda T; Takaya A; Kubo T; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Sato N; Torigoe T
    Biochem Biophys Res Commun; 2016 Apr; 472(4):643-7. PubMed ID: 26969274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging, tracking, and targeting of cancer stem cells.
    Vlashi E; Kim K; Lagadec C; Donna LD; McDonald JT; Eghbali M; Sayre JW; Stefani E; McBride W; Pajonk F
    J Natl Cancer Inst; 2009 Mar; 101(5):350-9. PubMed ID: 19244169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
    PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential remodeling of extracellular matrices by breast cancer initiating cells.
    Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
    J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
    Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.